Received: 24 May 2020
Accepted: 18 November 2020
First Online: 27 November 2020
Ethics approval and consent to participate
: The trial has received ethical approval from the Ethics Committee of NNFTRI (2018-10-20: Ethical code: IR.SBMU.nnftri.Rec.1397.248). Informed consent will be obtained from all participants by HE.
: All authors gave their consent for publication. Consent from the patients has been obtained for publications of non-identifiable information about them.
: The authors declared that there is no conflict of interest.